首页 | 本学科首页   官方微博 | 高级检索  
     


Long‐term follow‐up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation study
Authors:Martina Sterneck  Gernot M. Kaiser  Nils Heyne  Nicolas Richter  Falk Rauchfuss  Andreas Pascher  Peter Schemmer  Lutz Fischer  Christian G. Klein  Silvio Nadalin  Frank Lehner  Utz Settmacher  Daniel Gotthardt  Martin Loss  Stephan Ladenburger  Peter Wimmer  Markus Dworak  Hans J. Schlitt
Affiliation:1. Department of Medicine, University Medical Center Hamburg‐Eppendorf, Hamburg, Germany;2. Department of General, Visceral and Transplantation Surgery, Essen University Hospital, Essen, Germany;3. Department of General and Visceral Surgery, St. Bernhard‐Hospital Kamp‐Lintfort, Kamp‐Lintfort, Germany;4. Department of General, Visceral and Transplant Surgery, University Hospital Tuebingen, Tuebingen, Germany;5. Clinic for General, Abdominal and Transplant Surgery, Hannover Medical School (MHH), Hannover, Germany;6. Department of General, Abdominal and Vascular Surgery, Jena University Hospital, Jena, Germany;7. Clinic for General, Abdominal and Transplant Surgery, Charité University Medical Center Berlin, Berlin, Germany;8. Department of General, Visceral and Transplant Surgery, University Hospital Heidelberg, Heidelberg, Germany;9. Department of Surgery, University Hospital Regensburg, Regensburg, Germany;10. Novartis Pharma GmbH, Nürnberg, Germany
Abstract:
Keywords:calcineurin inhibitors  everolimus  long‐term follow‐up  renal function
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号